China Pharma Holdings (CPHI) Invested Capital (2010 - 2026)

China Pharma Holdings has reported Invested Capital for 17 years, with the latest figure at $39.0 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 379.53% year-over-year to $39.0 million; the trailing twelve-month figure through Mar 2026 stood at $39.0 million (up 379.53% YoY), and the FY2025 full-year result was $24.7 million, up 182.05% from the prior year.
• Invested Capital for Q1 2026 stood at $39.0 million, up from $24.7 million in the prior quarter.
• The five-year high for Invested Capital was $39.0 million in Q1 2026, with the low at $4.7 million in Q4 2022.
• Historically, Invested Capital has averaged $10.7 million across 5 years, with a median of $8.1 million in 2025.
• Annual changes were most pronounced in 2022 — Invested Capital slumped 54.29% — and 2026, when it soared 379.53%.
• China Pharma Holdings' Invested Capital stood at $4.7 million in 2022, then surged by 81.57% to $8.6 million in 2023, then increased by 2.04% to $8.8 million in 2024, then surged by 182.05% to $24.7 million in 2025, then jumped by 57.6% to $39.0 million in 2026.
• The last three Invested Capital figures came in at $39.0 million (Q1 2026), $24.7 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.